Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKP-11 topical gel for inflammatory arthritis
ACTRN12616000922471Phase 2Completed
- Sponsor
- Akaal Pharma Pty Ltd
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in arthritis, gout and rheumatoid arthritis (RA) comparing AKP-11 gel with Placebo gel (2 arms). Primary endpoints: Safety of AKP-11 gel, Change in Patient Global Assessment of Response to Treatment and 1 more. Started Aug 2016; status: completed.
02
Drugs
akp-11
03
Conditions
arthritisgoutrheumatoid arthritis (RA)
Beyond the preview
Go deeper on ACTRN12616000922471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000922471.